NCT05796791View on ClinicalTrials.gov

Ketamine and Motivational Enhancement Therapy for the Treatment of Tobacco Use Disorder

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

May 2, 2023

Primary Completion Date

June 30, 2024

Study Completion Date

June 30, 2024

Conditions
Tobacco UseSmoking CessationNicotine Dependence
Interventions
DRUG

Ketamine Hydrochloride

IM ketamine given in weekly session for a total of 3 weeks

BEHAVIORAL

Motivational enhancement therapy

Brief motivational based therapy

Trial Locations (1)

29412

Medical University of South Carolina, Charleston

All Listed Sponsors
lead

Medical University of South Carolina

OTHER

NCT05796791 - Ketamine and Motivational Enhancement Therapy for the Treatment of Tobacco Use Disorder | Biotech Hunter | Biotech Hunter